Anchor Drugs Pharmacy (Jajco Inc.), South San Francisco, CA

Is Anchor Drugs Pharmacy (Jajco Inc.) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Anchor Drugs Pharmacy (Jajco Inc.) hold a California pharmacy license?

No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones.

Has Anchor Drugs Pharmacy (Jajco Inc.) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (Dec 6, 2019), 1 state referral letter (Dec 6, 2019) and 1 FMD-145 letter (Dec 6, 2019) for Anchor Drugs Pharmacy (Jajco Inc.). State board actions: no California State Board of Pharmacy action under this exact name and city was found in the board’s posted disciplinary decisions on facility licenses (actions dated Jan 5, 2005 to Oct 28, 2026) on Nov 6, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Jajco Inc.; Anchor Drugs Pharmacy
Location
South San Francisco, CA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Dec 6, 2019
FDA Data Dashboard inspections
2 inspections: 1 OAI, 1 VAI; 2 published Form 483s
Form 483 text on this page
1 Form 483, 2 observations
State board records
No exact match

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Jajco Inc. (dba Anchor Drugs Pharmacy), a 503A facility, with 3 dated actions.

Document
Dec 6, 2019State referral letterReferral Letter to the California State Board of Pharmacy Issued 12/06/2019FDA copy (archived)
Dec 6, 2019FMD-145 letterFMD-145 Letter Issued 12/06/2019FDA copy (archived)
Dec 6, 2019Warning letter close-outWarning Letter Close Out Issued 12/06/2019Not linked by FDA

An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Jajco, Inc., South San Francisco, CA (FEI number 3012327563), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Oct 29, 2018Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30123275631070915
Jun 3, 2016Official Action Indicated (OAI)Drug Quality Assurance (Drugs)3012327563974160

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Oct 24, 2018 to Oct 29, 2018: 2 observations

Firm on the cover
Jajco, Inc. DBA Anchor Drugs Pharmacy, 161 s Spruce Ave, South San Francisco, CA 94080-4517
FEI number
3012327563
Establishment type on the cover
Producer of Non-Sterile Drug Products
FDA district office on the cover
1431 Harbor Bay Parkway Alameda, CA 94502-7070
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

You produced hazardous drugs without providing adequate cleaning of work surfaces and cleaning of utensils to prevent cross-contamination.

Specifically ,

Your firm's cleaning of utensils, equipment, and work surfaces is inadequate. Your firm uses <Redacted B4> to mix drug substance including testosterone and estradiol. This type of glassware is cleaned in a dishwasher using store bought detergent. Your firm also uses dish soap and lint free wipes to clean the encapsulation equipment and <Redacted B4> our firm does not use dedicated equipment for hazardous diugs and your cleaning process is inadequate to prevent cross-contamination.

Observation 2

Non-microbial contamination was observed in your production area.

Specifically,

Linked 483s whose text is not shown

State board of pharmacy records

No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones. Board file.

What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.